Type 2 Diabetes: The Pathologic Basis of Reversible ß-Cell Dysfunction. (2016)
Attributed to:
Overcoming immunological barriers to regenerative medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/dc16-0619
PubMed Identifier: 27926891
Publication URI: http://europepmc.org/abstract/MED/27926891
Type: Journal Article/Review
Volume: 39
Parent Publication: Diabetes care
Issue: 11
ISSN: 0149-5992